CEO to Step Back to Undergo Treatment for Cancer
Due to cancer, Baloise Group CEO Gert De Winter will probably only perform his function to a limited extent until summer 2022 in order to concentrate on medical treatment. He will continue to accompany the strategically relevant topics, in particular the start of the "Simply Safe: Season 2" strategy program….
Continue Reading
Subscribe to unlock the full article and access premium financial content.

